Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bristol Myers Squibb Income After Taxes 2010-2023 | BMY

Bristol Myers Squibb annual/quarterly income after taxes history and growth rate from 2010 to 2023. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
  • Bristol Myers Squibb income after taxes for the quarter ending December 31, 2023 was $1.762B, a 12.99% decline year-over-year.
  • Bristol Myers Squibb income after taxes for the twelve months ending December 31, 2023 was $8.040B, a 26.71% increase year-over-year.
  • Bristol Myers Squibb annual income after taxes for 2023 was $8.04B, a 26.71% increase from 2022.
  • Bristol Myers Squibb annual income after taxes for 2022 was $6.345B, a 9.54% decline from 2021.
  • Bristol Myers Squibb annual income after taxes for 2021 was $7.014B, a 177.98% decline from 2020.
  
Bristol Myers Squibb Annual Income After Taxes
(Millions of US $)
2023 $8,040
2022 $6,345
2021 $7,014
2020 $-8,995
2019 $3,460
2018 $4,947
2017 $975
2016 $4,507
2015 $1,631
2014 $2,029
2013 $2,580
2012 $2,501
2011 $5,260
2010 $4,513
2009 $4,420
Bristol Myers Squibb Quarterly Income After Taxes
(Millions of US $)
2023-12-31 $1,762
2023-09-30 $1,934
2023-06-30 $2,077
2023-03-31 $2,267
2022-12-31 $2,025
2022-09-30 $1,608
2022-06-30 $1,429
2022-03-31 $1,283
2021-12-31 $2,372
2021-09-30 $1,552
2021-06-30 $1,061
2021-03-31 $2,029
2020-12-31 $-10,027
2020-09-30 $1,878
2020-06-30 $-80
2020-03-31 $-766
2019-12-31 $-1,060
2019-09-30 $1,366
2019-06-30 $1,439
2019-03-31 $1,715
2018-12-31 $1,158
2018-09-30 $1,912
2018-06-30 $382
2018-03-31 $1,495
2017-12-31 $-2,329
2017-09-30 $856
2017-06-30 $922
2017-03-31 $1,526
2016-12-31 $898
2016-09-30 $1,215
2016-06-30 $1,188
2016-03-31 $1,206
2015-12-31 $-188
2015-09-30 $730
2015-06-30 $-110
2015-03-31 $1,199
2014-12-31 $27
2014-09-30 $732
2014-06-30 $334
2014-03-31 $936
2013-12-31 $735
2013-09-30 $692
2013-06-30 $530
2013-03-31 $623
2012-12-31 $924
2012-09-30 $-713
2012-06-30 $808
2012-03-31 $1,482
2011-12-31 $1,231
2011-09-30 $1,355
2011-06-30 $1,307
2011-03-31 $1,367
2010-12-31 $842
2010-09-30 $1,302
2010-06-30 $1,268
2010-03-31 $1,101
2009-12-31 $1,132
2009-09-30 $1,199
2009-06-30 $1,169
2009-03-31 $920
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $90.692B $45.006B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $167.829B 16.79
Vertex Pharmaceuticals (VRTX) United States $108.122B 27.82
Regeneron Pharmaceuticals (REGN) United States $106.250B 26.08
GSK (GSK) United Kingdom $92.576B 11.06
CSL (CSLLY) Australia $88.667B 0.00
Gilead Sciences (GILD) United States $80.457B 16.02
Moderna (MRNA) United States $47.020B 0.00
Biogen (BIIB) United States $32.432B 14.85
Argenex SE (ARGX) Netherlands $22.735B 0.00
BioNTech SE (BNTX) Germany $21.885B 184.12
Alnylam Pharmaceuticals (ALNY) United States $19.147B 0.00
Genmab (GMAB) Denmark $19.050B 22.33
Illumina (ILMN) United States $17.738B 126.53
BeiGene (BGNE) Cayman Islands $16.129B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.517B 60.53
Bio-Techne Corp (TECH) United States $12.548B 47.40
Sarepta Therapeutics (SRPT) United States $12.505B 1102.50
Incyte (INCY) United States $12.013B 18.58
Exact Sciences (EXAS) United States $9.992B 0.00
QIAGEN (QGEN) Netherlands $9.945B 21.25
Repligen (RGEN) United States $9.213B 120.36
Roivant Sciences (ROIV) United Kingdom $9.066B 0.00
Viking Therapeutics (VKTX) United States $8.844B 0.00
Legend Biotech (LEGN) United States $8.281B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.983B 26.11
Ascendis Pharma (ASND) Denmark $7.751B 0.00
Vaxcyte (PCVX) United States $7.134B 0.00
Intra-Cellular Therapies (ITCI) United States $6.921B 0.00
Blueprint Medicines (BPMC) United States $6.630B 0.00
Exelixis (EXEL) United States $6.598B 34.00
Cytokinetics (CYTK) United States $6.594B 0.00
Halozyme Therapeutics (HALO) United States $5.580B 15.49
ImmunityBio (IBRX) United States $5.457B 0.00
Apellis Pharmaceuticals (APLS) United States $5.160B 0.00
Zealand Pharma (ZLDPF) Denmark $4.775B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.547B 0.00
Krystal Biotech (KRYS) United States $4.533B 0.00
Nuvalent (NUVL) United States $4.326B 0.00
Immunovant (IMVT) United States $4.315B 0.00
Alkermes (ALKS) Ireland $4.105B 16.07
Insmed (INSM) United States $3.919B 0.00
Iovance Biotherapeutics (IOVA) United States $3.764B 0.00
Biohaven (BHVN) United States $3.650B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.628B 0.00
Axsome Therapeutics (AXSM) United States $3.499B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.427B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.206B 0.00
Fortrea Holdings (FTRE) United States $3.200B 0.00
SpringWorks Therapeutics (SWTX) United States $3.182B 0.00
IDEAYA Biosciences (IDYA) United States $3.076B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.982B 0.00
Arcellx (ACLX) United States $2.810B 0.00
Amicus Therapeutics (FOLD) United States $2.808B 0.00
Certara (CERT) United States $2.744B 63.19
Celldex Therapeutics (CLDX) United States $2.706B 0.00
Janux Therapeutics (JANX) United States $2.693B 0.00
MorphoSys AG (MOR) Germany $2.692B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.681B 0.00
Denali Therapeutics (DNLI) United States $2.663B 0.00
Merus (MRUS) Netherlands $2.648B 0.00
Avidity Biosciences (RNA) United States $2.591B 0.00
Twist Bioscience (TWST) United States $2.515B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.513B 0.00
Intellia Therapeutics (NTLA) United States $2.397B 0.00
Kymera Therapeutics (KYMR) United States $2.369B 0.00
Guardant Health (GH) United States $2.366B 0.00
Vericel (VCEL) United States $2.364B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.347B 0.00
Vera Therapeutics (VERA) United States $2.305B 0.00
Geron (GERN) United States $2.301B 0.00
Myriad Genetics (MYGN) United States $2.285B 0.00
Apogee Therapeutics (APGE) United States $2.272B 0.00
Arvinas (ARVN) United States $2.186B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.118B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.086B 0.00
Zai Lab (ZLAB) China $2.084B 0.00
Keros Therapeutics (KROS) United States $2.078B 0.00
CG Oncology (CGON) United States $2.000B 0.00
Ginkgo Bioworks Holdings (DNA) United States $1.980B 0.00
NeoGenomics (NEO) United States $1.980B 0.00
Galapagos (GLPG) Belgium $1.896B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.867B 0.00
Edgewise Therapeutics (EWTX) United States $1.862B 0.00
Beam Therapeutics (BEAM) United States $1.855B 0.00
Inhibrx (INBX) United States $1.814B 0.00
Structure Therapeutics (GPCR) United States $1.801B 0.00
Bavarian Nordic (BVNRY) Denmark $1.796B 7.82
Harmony Biosciences Holdings (HRMY) United States $1.776B 13.54
Sana Biotechnology (SANA) United States $1.661B 0.00
Protagonist Therapeutics (PTGX) United States $1.658B 11.59
Kura Oncology (KURA) United States $1.582B 0.00
ADMA Biologics Inc (ADMA) United States $1.582B 63.00
Neumora Therapeutics (NMRA) United States $1.559B 0.00
Ligand Pharmaceuticals (LGND) United States $1.547B 25.33
Arcus Biosciences (RCUS) United States $1.469B 0.00
Morphic Holding (MORF) United States $1.459B 0.00
Dynavax Technologies (DVAX) United States $1.441B 183.50
Akero Therapeutics (AKRO) United States $1.438B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.432B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.431B 0.00
ANI Pharmaceuticals (ANIP) United States $1.389B 17.07
Gyre Therapeutics (GYRE) United States $1.301B 0.00
Vir Biotechnology (VIR) United States $1.301B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.286B 0.00
Spyre Therapeutics (SYRE) United States $1.272B 0.00
Belite Bio (BLTE) United States $1.239B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.217B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.192B 0.00
Prothena (PRTA) Ireland $1.183B 0.00
MannKind (MNKD) United States $1.174B 143.67
Cullinan Therapeutics (CGEM) United States $1.170B 0.00
AbCellera Biologics (ABCL) Canada $1.162B 0.00
Scholar Rock Holding (SRRK) United States $1.160B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.109B 0.00
MiMedx (MDXG) United States $1.069B 45.25
Liquidia Technologies (LQDA) United States $0.953B 0.00
Tyra Biosciences (TYRA) United States $0.933B 0.00
Immunome (IMNM) United States $0.928B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.927B 0.00
Immatics (IMTX) Germany $0.901B 0.00
Abivax SA (ABVX) France $0.890B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.889B 0.00
Viridian Therapeutics (VRDN) United States $0.888B 0.00
89BIO (ETNB) United States $0.868B 0.00
Praxis Precision Medicines (PRAX) United States $0.857B 0.00
ALX Oncology Holdings (ALXO) United States $0.848B 0.00
Pliant Therapeutics (PLRX) United States $0.833B 0.00
Tango Therapeutics (TNGX) United States $0.830B 0.00
Mesoblast (MESO) Australia $0.819B 0.00
Cytek Biosciences (CTKB) United States $0.814B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.792B 0.00
REGENXBIO (RGNX) United States $0.772B 0.00
Cogent Biosciences (COGT) United States $0.757B 0.00
CARGO Therapeutics (CRGX) United States $0.748B 0.00
Disc Medicine (IRON) United States $0.743B 0.00
PureTech Health (PRTC) United States $0.741B 0.00
Dianthus Therapeutics (DNTH) United States $0.732B 0.00
Nuvation Bio (NUVB) United States $0.726B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.722B 0.00
AnaptysBio (ANAB) United States $0.717B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.708B 0.00
Mineralys Therapeutics (MLYS) United States $0.708B 0.00
WAVE Life Sciences (WVE) Singapore $0.705B 0.00
HilleVax (HLVX) United States $0.696B 0.00
Prime Medicine (PRME) United States $0.687B 0.00
Nurix Therapeutics (NRIX) United States $0.686B 0.00
Castle Biosciences (CSTL) United States $0.674B 0.00
CureVac (CVAC) Germany $0.667B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.660B 0.00
Zymeworks (ZYME) United States $0.653B 0.00
Pharming Group (PHAR) Netherlands $0.650B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.641B 0.00
Oric Pharmaceuticals (ORIC) United States $0.641B 0.00
Kyverna Therapeutics (KYTX) United States $0.629B 0.00
Novavax (NVAX) United States $0.628B 0.00
EnGene Holdings (ENGN) United States $0.628B 0.00
Stoke Therapeutics (STOK) United States $0.626B 0.00
GH Research (GHRS) Ireland $0.624B 0.00
Pharming Group (PHGUF) Netherlands $0.622B 0.00
ArriVent BioPharma (AVBP) United States $0.603B 0.00
Aerovate Therapeutics (AVTE) United States $0.602B 0.00
Northwest Biotherapeutics (NWBO) United States $0.596B 0.00
IGM Biosciences (IGMS) United States $0.595B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.591B 0.00
Absci (ABSI) United States $0.581B 0.00
Cabaletta Bio (CABA) United States $0.572B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.565B 0.00
Astria Therapeutics (ATXS) United States $0.558B 0.00
Arbutus Biopharma (ABUS) United States $0.555B 0.00
Olema Pharmaceuticals (OLMA) United States $0.550B 0.00
Humacyte (HUMA) United States $0.538B 0.00
Celcuity (CELC) United States $0.528B 0.00
Applied Therapeutics (APLT) United States $0.528B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.527B 0.00
Adaptive Biotechnologies (ADPT) United States $0.525B 0.00
Avid Bioservices (CDMO) United States $0.517B 0.00
Shattuck Labs (STTK) United States $0.507B 0.00
Travere Therapeutics (TVTX) United States $0.502B 0.00
Third Harmonic Bio (THRD) United States $0.501B 0.00
Alector (ALEC) United States $0.501B 0.00
MaxCyte (MXCT) United States $0.494B 0.00
Allogene Therapeutics (ALLO) United States $0.488B 0.00
Entrada Therapeutics (TRDA) United States $0.485B 22.79
Oculis Holding AG (OCS) Switzerland $0.485B 0.00
ACELYRIN, INC (SLRN) United States $0.483B 0.00
Adlai Nortye (ANL) Cayman Islands $0.480B 0.00
C4 Therapeutics (CCCC) United States $0.468B 0.00
Fulcrum Therapeutics (FULC) United States $0.466B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.465B 0.00
Annexon (ANNX) United States $0.465B 0.00
Voyager Therapeutics (VYGR) United States $0.459B 2.73
MEREO BIOPHARMA (MREO) United Kingdom $0.459B 0.00
Editas Medicine (EDIT) United States $0.457B 0.00
Revance Therapeutics (RVNC) United States $0.447B 0.00
Fate Therapeutics (FATE) United States $0.444B 0.00
ITeos Therapeutics (ITOS) United States $0.438B 0.00
PepGen (PEPG) United States $0.432B 0.00
Ocugen (OCGN) United States $0.430B 0.00
Neurogene (NGNE) United States $0.427B 0.00
Replimune (REPL) United States $0.413B 0.00
Biomea Fusion (BMEA) United States $0.411B 0.00
Alto Neuroscience (ANRO) United States $0.393B 0.00
Solid Biosciences (SLDB) United States $0.391B 0.00
Terns Pharmaceuticals (TERN) United States $0.379B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.378B 0.00
Anika Therapeutics (ANIK) United States $0.375B 315.75
Aura Biosciences (AURA) United States $0.373B 0.00
TScan Therapeutics (TCRX) United States $0.373B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.372B 0.00
Amarin (AMRN) Ireland $0.361B 0.00
Tenaya Therapeutics (TNYA) United States $0.352B 0.00
Nautilus Biotechnology (NAUT) United States $0.351B 0.00
Rani Therapeutics Holdings (RANI) United States $0.340B 0.00
Erasca (ERAS) United States $0.340B 0.00
Atea Pharmaceuticals (AVIR) United States $0.331B 0.00
Caribou Biosciences (CRBU) United States $0.330B 0.00
MeiraGTx Holdings (MGTX) United States $0.328B 0.00
Jasper Therapeutics (JSPR) United States $0.323B 0.00
Precigen (PGEN) United States $0.321B 0.00
Kamada (KMDA) Israel $0.320B 24.17
Anavex Life Sciences (AVXL) United States $0.319B 0.00
Ventyx Biosciences (VTYX) United States $0.316B 0.00
Nkarta (NKTX) United States $0.311B 0.00
Urogen Pharma (URGN) United States $0.304B 0.00
Verastem (VSTM) United States $0.302B 0.00
Mersana Therapeutics (MRSN) United States $0.299B 0.00
CorMedix Inc (CRMD) United States $0.297B 0.00
Candel Therapeutics (CADL) United States $0.293B 0.00
Contineum Therapeutics (CTNM) United States $0.292B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.292B 0.00
Invivyd (IVVD) United States $0.289B 0.00
Inozyme Pharma (INZY) United States $0.288B 0.00
FibroBiologics (FBLG) United States $0.285B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.281B 0.00
XOMA (XOMA) United States $0.276B 0.00
Sutro Biopharma (STRO) United States $0.272B 0.00
Design Therapeutics (DSGN) United States $0.269B 0.00
ChromaDex (CDXC) United States $0.266B 0.00
Prima BioMed (IMMP) Australia $0.265B 0.00
Poseida Therapeutics (PSTX) United States $0.263B 0.00
XBiotech (XBIT) United States $0.262B 0.00
Inovio Pharmaceuticals (INO) United States $0.261B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.261B 0.00
G1 Therapeutics (GTHX) United States $0.260B 0.00
23andMe Holding (ME) United States $0.246B 0.00
UniQure (QURE) Netherlands $0.246B 0.00
Agenus (AGEN) United States $0.246B 0.00
Codexis (CDXS) United States $0.245B 0.00
Werewolf Therapeutics (HOWL) United States $0.242B 0.00
Coherus BioSciences (CHRS) United States $0.241B 0.00
AC Immune (ACIU) Switzerland $0.232B 0.00
Puma Biotechnology (PBYI) United States $0.231B 14.52
Emergent Biosolutions (EBS) United States $0.229B 0.00
2seventy Bio (TSVT) United States $0.228B 0.00
Opthea (OPT) Australia $0.222B 0.00
Akoya Biosciences (AKYA) United States $0.221B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.219B 0.00
Compass Therapeutics (CMPX) United States $0.219B 0.00
Ovid Therapeutics (OVID) United States $0.216B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.214B 0.00
Trevi Therapeutics (TRVI) United States $0.206B 0.00
Innate Pharma S.A (IPHA) France $0.203B 0.00
Boundless Bio (BOLD) $0.202B 0.00
Kodiak Sciences (KOD) United States $0.200B 0.00
Adverum Biotechnologies (ADVM) United States $0.199B 0.00
Lifecore Biomedical (LFCR) United States $0.199B 0.00
Zura Bio (ZURA) United States $0.198B 0.00
INmune Bio (INMB) United States $0.196B 0.00
Elevation Oncology (ELEV) United States $0.192B 0.00
GENFIT S.A (GNFT) France $0.186B 0.00
Compugen (CGEN) Israel $0.181B 0.00
Greenwich LifeSciences (GLSI) United States $0.180B 0.00
Cellectis S.A (CLLS) France $0.180B 0.00
Inventiva S.A (IVA) France $0.180B 0.00
X4 Pharmaceuticals (XFOR) United States $0.179B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.177B 0.00
Alimera Sciences (ALIM) United States $0.177B 0.00
ScPharmaceuticals (SCPH) United States $0.173B 0.00
Renovaro (RENB) United States $0.172B 0.00
Adocia (ADOCY) France $0.169B 0.00
Gossamer Bio (GOSS) United States $0.169B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.163B 0.00
Rapt Therapeutics (RAPT) United States $0.162B 0.00
CytomX Therapeutics (CTMX) United States $0.159B 10.20
Seres Therapeutics (MCRB) United States $0.156B 0.00
Repare Therapeutics (RPTX) Canada $0.155B 0.00
BioStem Technologies (BSEM) $0.152B 0.00
Cardiff Oncology (CRDF) United States $0.151B 0.00
Skye Bioscience (SKYE) United States $0.149B 0.00
CervoMed (CRVO) United States $0.147B 0.00
I-Mab (IMAB) China $0.146B 0.00
Sagimet Biosciences (SGMT) United States $0.146B 0.00
PDS Biotechnology (PDSB) United States $0.140B 0.00
BioAtla (BCAB) United States $0.140B 0.00
Scilex Holding (SCLX) United States $0.138B 0.00
Molecular Partners AG (MOLN) Switzerland $0.135B 0.00
Adicet Bio (ACET) United States $0.134B 0.00
Syros Pharmaceuticals (SYRS) United States $0.134B 0.00
Seer (SEER) United States $0.133B 0.00
Coya Therapeutics (COYA) United States $0.124B 0.00
Vor Biopharma (VOR) $0.123B 0.00
Vigil Neuroscience (VIGL) United States $0.123B 0.00
DiaMedica Therapeutics (DMAC) United States $0.123B 0.00
Bluebird Bio (BLUE) United States $0.122B 0.00
TELA Bio (TELA) United States $0.122B 0.00
Abeona Therapeutics (ABEO) United States $0.122B 0.00
VistaGen Therapeutics (VTGN) United States $0.121B 0.00
Omega Therapeutics (OMGA) United States $0.120B 0.00
ATyr Pharma (LIFE) United States $0.119B 0.00
Nuvectis Pharma (NVCT) United States $0.117B 0.00
Cartesian Therapeutics (RNAC) United States $0.117B 0.00
Rezolute (RZLT) United States $0.114B 0.00
Allakos (ALLK) United States $0.114B 0.00
Immunic (IMUX) United States $0.112B 0.00
DBV Technologies S.A (DBVT) France $0.110B 0.00
Sangamo Therapeutics (SGMO) United States $0.109B 0.00
Genelux (GNLX) United States $0.108B 0.00
Gritstone Bio (GRTS) United States $0.104B 0.00
IO Biotech (IOBT) Denmark $0.104B 0.00
Clearside Biomedical (CLSD) United States $0.101B 0.00
Oncobiologics (OTLK) United States $0.101B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.100B 0.00
Curis (CRIS) United States $0.097B 0.00
Elicio Therapeutics (ELTX) United States $0.097B 0.00
BioHarvest Sciences (CNVCF) Canada $0.097B 0.00
Oncolytics Biotech (ONCY) Canada $0.094B 0.00
Adagene (ADAG) China $0.094B 0.00
Cue Biopharma (CUE) United States $0.093B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.092B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.091B 0.00
Spero Therapeutics (SPRO) United States $0.091B 3.38
BeyondSpring (BYSI) United States $0.091B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.090B 0.00
Passage Bio (PASG) United States $0.090B 0.00
YS Biopharma (YS) China $0.089B 0.00
Eton Pharmaceuticals (ETON) United States $0.088B 85.88
Q32 Bio (QTTB) United States $0.087B 0.00
BioXcel Therapeutics (BTAI) United States $0.085B 0.00
Athira Pharma (ATHA) United States $0.085B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.082B 0.00
VTv Therapeutics (VTVT) United States $0.081B 0.00
Eupraxia Pharmaceuticals (EPRX) $0.080B 0.00
Affimed (AFMD) Germany $0.080B 0.00
HOOKIPA Pharma (HOOK) United States $0.079B 0.00
Connect Biopharma Holdings (CNTB) United States $0.079B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.077B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.077B 0.00
Cognition Therapeutics (CGTX) United States $0.077B 0.00
Precision BioSciences (DTIL) United States $0.076B 0.00
Galena Biopharma (SLS) United States $0.075B 0.00
Leap Therapeutics (LPTX) United States $0.075B 0.00
Alpha Teknova (TKNO) United States $0.074B 0.00
AN2 Therapeutics (ANTX) United States $0.074B 0.00
Lantern Pharma (LTRN) United States $0.073B 0.00
Entera Bio (ENTX) Israel $0.073B 0.00
Instil Bio (TIL) United States $0.073B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.072B 0.00
Rallybio (RLYB) United States $0.072B 0.00
MediciNova (MNOV) United States $0.072B 0.00
InflaRx (IFRX) Germany $0.071B 0.00
Landos Biopharma (LABP) United States $0.070B 0.00
Elutia (ELUT) United States $0.068B 0.00
Annovis Bio (ANVS) United States $0.066B 0.00
Turnstone Biologics (TSBX) United States $0.066B 0.00
Atara Biotherapeutics (ATRA) United States $0.066B 0.00
Bionano Genomics (BNGO) United States $0.066B 0.00
Ikena Oncology (IKNA) United States $0.065B 0.00
Equillium (EQ) United States $0.063B 0.00
China Health Industries Holdings (CHHE) China $0.063B 0.00
Kronos Bio (KRON) United States $0.063B 0.00
Aileron Therapeutics (ALRN) United States $0.062B 0.00
CalciMedica (CALC) United States $0.061B 0.00
Ocean Biomedical (OCEA) United States $0.060B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.060B 0.00
Kezar Life Sciences (KZR) United States $0.059B 0.00
Celularity (CELU) United States $0.059B 0.00
Genenta Science S.p.A (GNTA) Italy $0.059B 0.00
Aligos Therapeutics (ALGS) United States $0.059B 0.00
Immix Biopharma (IMMX) United States $0.058B 0.00
Cidara Therapeutics (CDTX) United States $0.057B 0.00
LENZ Therapeutics (LENZ) United States $0.056B 0.00
AVROBIO (AVRO) United States $0.056B 0.00
Checkpoint Therapeutics (CKPT) United States $0.056B 0.00
Enzo Biochem (ENZ) United States $0.053B 0.00
Intensity Therapeutics (INTS) United States $0.052B 0.00
Ocuphire Pharma (OCUP) United States $0.050B 0.00
Clene (CLNN) United States $0.050B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.049B 0.00
ARCA Biopharma (ABIO) United States $0.049B 0.00
NextCure (NXTC) United States $0.048B 0.00
Xilio Therapeutics (XLO) United States $0.047B 0.00
Lexaria Bioscience (LEXX) Canada $0.046B 0.00
Immuneering (IMRX) United States $0.046B 0.00
Aadi Bioscience (AADI) United States $0.046B 0.00
HCW Biologics (HCWB) United States $0.045B 0.00
IN8bio (INAB) United States $0.044B 0.00
OKYO Pharma (OKYO) $0.044B 0.00
Dyadic (DYAI) United States $0.044B 0.00
Beyond Air (XAIR) United States $0.043B 0.00
Bolt Biotherapeutics (BOLT) United States $0.043B 0.00
Carmell (CTCX) United States $0.042B 0.00
Cyclo Therapeutics (CYTH) United States $0.042B 0.00
Cara Therapeutics (CARA) United States $0.042B 0.00
Eyenovia (EYEN) United States $0.041B 0.00
Quince Therapeutics (QNCX) United States $0.040B 0.00
Sensei Biotherapeutics (SNSE) United States $0.039B 0.00
Estrella Immunopharma (ESLA) United States $0.039B 0.00
SAB Biotherapeutics (SABS) United States $0.037B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.037B 0.00
BRIACELL THERAP (BCTX) Canada $0.036B 0.00
Apollomics (APLM) United States $0.035B 0.00
Spruce Biosciences (SPRB) United States $0.035B 0.00
Promis Neurosciences (PMN) Canada $0.034B 0.00
Fortress Biotech (FBIO) United States $0.033B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.032B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.032B 0.00
Dare Bioscience (DARE) United States $0.032B 0.00
MiNK Therapeutics (INKT) United States $0.031B 0.00
Pluri (PLUR) Israel $0.031B 0.00
Theratechnologies (THTX) Canada $0.030B 0.00
Aprea Therapeutics (APRE) United States $0.030B 0.00
Evogene (EVGN) Israel $0.029B 0.00
NKGen Biotech (NKGN) United States $0.028B 0.00
Femasys (FEMY) United States $0.028B 0.00
UNITY Biotechnology (UBX) United States $0.027B 0.00
Biora Therapeutics (BIOR) United States $0.027B 0.00
Forte Biosciences (FBRX) United States $0.027B 0.00
Lumos Pharma (LUMO) United States $0.025B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
Benitec Biopharma (BNTC) United States $0.024B 0.00
BioAffinity Technologies (BIAF) United States $0.023B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.023B 0.00
RenovoRx (RNXT) United States $0.023B 0.00
Synlogic (SYBX) United States $0.021B 0.00
Aptose Biosciences (APTO) Canada $0.020B 0.00
Evaxion Biotech (EVAX) Denmark $0.020B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.020B 0.00
Orgenesis (ORGS) United States $0.019B 0.00
Galecto (GLTO) Denmark $0.019B 0.00
KALA BIO (KALA) United States $0.019B 0.00
Vincerx Pharma (VINC) United States $0.018B 0.00
Aytu BioPharma (AYTU) United States $0.018B 0.00
Cocrystal Pharma (COCP) United States $0.018B 0.00
VBI Vaccines (VBIV) United States $0.017B 0.00
Senti Biosciences (SNTI) United States $0.017B 0.00
Talis Biomedical (TLIS) United States $0.017B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.016B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.016B 0.00
Semper Paratus Acquisition (TVGN) United States $0.016B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
Imunon (IMNN) United States $0.014B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.014B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
Purple Biotech (PPBT) Israel $0.013B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.013B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.013B 0.00
Monopar Therapeutics (MNPR) United States $0.012B 0.00
Elevai Labs (ELAB) United States $0.012B 0.00
Eterna Therapeutics (ERNA) United States $0.012B 0.00
ABVC BioPharma (ABVC) United States $0.012B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.011B 0.00
BioCardia (BCDA) United States $0.011B 0.00
Moleculin Biotech (MBRX) United States $0.011B 0.00
Telesis Bio (TBIO) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
Organovo Holdings (ONVO) United States $0.010B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
Psyence Biomedical (PBM) United States $0.010B 0.00
Galera Therapeutics (GRTX) United States $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Chemomab Therapeutics (CMMB) Israel $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Pasithea Therapeutics (KTTA) United States $0.008B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
Cadrenal Therapeutics (CVKD) United States $0.008B 0.00
Trevena (TRVN) United States $0.008B 0.00
NuCana (NCNA) United Kingdom $0.007B 0.00
Virios Therapeutics (VIRI) United States $0.007B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Kineta (KA) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Enveric Biosciences (ENVB) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Vaccinex (VCNX) United States $0.007B 0.00
Palisade Bio (PALI) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.006B 0.00
Kintara Therapeutics (KTRA) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Atrinsic (PTIX) United States $0.006B 0.00
First Wave BioPharma (FWBI) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.006B 0.00
TFF Pharmaceuticals (TFFP) United States $0.005B 0.00
ThermoGenesis Holdings (THMO) United States $0.005B 0.00
Cingulate (CING) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
NexImmune (NEXI) United States $0.005B 0.00
Novogen (KZIA) Australia $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.005B 0.00
Seelos Therapeutics (SEEL) United States $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
TRACON Pharmaceuticals (TCON) United States $0.004B 0.00
Alzamend Neuro (ALZN) United States $0.004B 0.00
Exicure (XCUR) United States $0.004B 0.28
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.004B 0.00
Longeveron (LGVN) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.003B 0.00
Notable Labs (NTBL) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
Mustang Bio (MBIO) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Sunshine Biopharma (SBFM) United States $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Aptevo Therapeutics (APVO) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00